Brought to you by 
FivePrime raises $12mm in round two
16 Apr 2021
Executive Summary
The two-year-old biotech FivePrime Therapeutics Inc. (protein and antibody discovery) has raised $12mm in its second financing. The round was led by previous investors Kleiner Perkins Caufield and Byers, TPG Ventures, and Versant Ventures.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Genomics-Proteomics
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
FivePrime raises $12mm in round two
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice